BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37106446)

  • 21. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
    Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. δ-Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β-catenin nuclear localization and activating its downstream target genes.
    Ju L; Shan L; Yin B; Song Y
    Cancer Med; 2020 Mar; 9(6):2201-2212. PubMed ID: 31991069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma.
    Liu Y; Chen K; Shou Y; Li S; Wang J; Zhang Q; Huang Z; Xu J; Li M; Liu D; Liang H; Yang H; Zhang X
    Clin Transl Med; 2023 Dec; 13(12):e1512. PubMed ID: 38073586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis.
    Sun J; Pan S; Cui H; Li H
    Curr Cancer Drug Targets; 2020; 20(6):461-470. PubMed ID: 32271695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1.
    Jin C; Shi L; Li K; Liu W; Qiu Y; Zhao Y; Zhao B; Li Z; Li Y; Zhu Q
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
    Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
    Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA FOXP1 Induced by ZNF263 Upregulates U2AF2 Expression to Accelerate Renal Cell Carcinoma Tumorigenesis and Warburg Effect through Sponging miR-423-5p.
    Fang L; Ye T; An Y
    J Immunol Res; 2021; 2021():8050993. PubMed ID: 34514002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
    Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
    Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
    Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
    PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of TACC3 Inhibits the Proliferation and Invasion of Human Renal Cell Carcinoma Cells.
    Guo F; Liu Y
    Oncol Res; 2018 Mar; 26(2):183-189. PubMed ID: 28109075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
    Hong Q; Li O; Zheng W; Xiao WZ; Zhang L; Wu D; Cai GY; He JC; Chen XM
    Cell Death Dis; 2017 May; 8(5):e2772. PubMed ID: 28492542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
    Zhai X; Wu Y; Zhang D; Li H; Chong T; Zhao J
    J Bioenerg Biomembr; 2021 Apr; 53(2):191-202. PubMed ID: 33686550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis.
    Shi J; Zhang D; Zhong Z; Zhang W
    Mol Med Rep; 2019 Oct; 20(4):3782-3792. PubMed ID: 31485634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment.
    Qin Y; Zhang M; Lei H; Wu H; Huang C; Zhou X; Fu Y; Weng M; Ma M
    Drug Dev Res; 2022 Dec; 83(8):1831-1844. PubMed ID: 36184877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.